PB0104 - Emergency Mobile and Point of Care Anticoagulation Clinic During (COVID-19) Curfew by Pharmacists in Saudi Arabia

Background: On January 30, 2020, In Saudi Arabia, as a part of its continuous efforts to prevent transmission of COVID-19 due to restricting movement. Patients on warfarin were monitored to help prevent serious side effects while maximizing effective treatment. we Established an emergency Mobile anticoagulation clinic (EMAC) managed by a pharmacist, this clinic was performed in Al Qatif City to manage warfarin doses according to patient INR,

Aims: The study is aiming to assess adherence, and satisfaction in all patients on warfarin therapy followed by the emergency anticoagulation service during the COVID-19 outbreak using a validated questionnaire.

Methods: The study identified 70 patients who visited the EMAC in Qatif city the eastern province of Saudi Arabia, during the COVID-19 outbreak (March 9 – April 26), 2020. The study included patients ≥18 years old on warfarin for follow-up, an observational prospective study using a validated questionnaire from three parts (Kansas City Cardiomyopathy Questionnaire (KCCQ), Minnesota Living with Heart Failure Questionnaire, and Morisky Medication Adherence scale (MMAS). Participants were advised to respond to the study questionnaire that assesses the following variables: INR compliance and management, Safety precautions for infection control practices, Management of medication, Trust in the point of care, and Clinic accessibility and services provided.

Results: 70 patients, 61.4% female, and 42.8% visited EMAC 3 times. 61.5% of patients received medical reconciliation based on their INR level. (84.3%) of patients reported strongly agreeing to adopt the provided service rather than regular hospital visits, to help stabilize INR within the target (95.7%), Moreover,91.4% of patients trust the point of care and 91.5% were satisfied with the instructions provided by the anticoagulant clinical pharmacist.

Conclusion(s): Our evidence supports pharmacists' role in improving patients’ outcomes during COVID-19. the remote EMAC provided an alternative solution for following-up cardiac patients that has a potential impact on medication management and patients’ satisfaction.